167 related articles for article (PubMed ID: 30954508)
21. Crystal structure of human estrogen-related receptor alpha in complex with a synthetic inverse agonist reveals its novel molecular mechanism.
Kallen J; Lattmann R; Beerli R; Blechschmidt A; Blommers MJ; Geiser M; Ottl J; Schlaeppi JM; Strauss A; Fournier B
J Biol Chem; 2007 Aug; 282(32):23231-9. PubMed ID: 17556356
[TBL] [Abstract][Full Text] [Related]
22. Cholesterol as an Endogenous Ligand of ERRα Promotes ERRα-Mediated Cellular Proliferation and Metabolic Target Gene Expression in Breast Cancer Cells.
Ghanbari F; Mader S; Philip A
Cells; 2020 Jul; 9(8):. PubMed ID: 32717915
[TBL] [Abstract][Full Text] [Related]
23. A Selective ERRα/γ Inverse Agonist, SLU-PP-1072, Inhibits the Warburg Effect and Induces Apoptosis in Prostate Cancer Cells.
Schoepke E; Billon C; Haynes KM; Avdagic A; Sitaula S; Sanders R; Adeyemi CM; Walker JK; Burris TP
ACS Chem Biol; 2020 Sep; 15(9):2338-2345. PubMed ID: 32897058
[TBL] [Abstract][Full Text] [Related]
24. The potential endocrine disruption mechanism of anthelmintic drug niclosamide by activating estrogen receptors and estrogen-related receptors.
He S; Li X; Ma JZ; Yang Y; Luo S; Xie XD; Yan BH; Yang J; Luo L; Cao LY
Toxicology; 2021 Jun; 457():152805. PubMed ID: 33961950
[TBL] [Abstract][Full Text] [Related]
25. Molecular dynamics of estrogen-related receptors and their regulatory proteins: roles in transcriptional control for endocrine and metabolic signaling.
Tanida T
Anat Sci Int; 2022 Jan; 97(1):15-29. PubMed ID: 34609710
[TBL] [Abstract][Full Text] [Related]
26. Estrogen receptor-related receptors: orphan receptors desperately seeking a ligand.
Horard B; Vanacker JM
J Mol Endocrinol; 2003 Dec; 31(3):349-57. PubMed ID: 14664699
[TBL] [Abstract][Full Text] [Related]
27. Cholesterol biosynthesis pathway as a novel mechanism of resistance to estrogen deprivation in estrogen receptor-positive breast cancer.
Simigdala N; Gao Q; Pancholi S; Roberg-Larsen H; Zvelebil M; Ribas R; Folkerd E; Thompson A; Bhamra A; Dowsett M; Martin LA
Breast Cancer Res; 2016 Jun; 18(1):58. PubMed ID: 27246191
[TBL] [Abstract][Full Text] [Related]
28. Expression of estrogen receptor-related receptor isoforms and clinical significance in endometrial adenocarcinoma.
Gao M; Sun P; Wang J; Zhao D; Wei L
Int J Gynecol Cancer; 2006; 16(2):827-33. PubMed ID: 16681769
[TBL] [Abstract][Full Text] [Related]
29. The estrogen-related receptors in metabolism and cancer: newer insights.
Ranhotra HS
J Recept Signal Transduct Res; 2018 Apr; 38(2):95-100. PubMed ID: 29619877
[TBL] [Abstract][Full Text] [Related]
30. Estrogen-related receptor alpha expression and function is associated with the transcriptional coregulator AIB1 in breast carcinoma.
Heck S; Rom J; Thewes V; Becker N; Blume B; Sinn HP; Deuschle U; Sohn C; Schneeweiss A; Lichter P
Cancer Res; 2009 Jun; 69(12):5186-93. PubMed ID: 19491275
[TBL] [Abstract][Full Text] [Related]
31. To ERR in the estrogen pathway.
Giguère V
Trends Endocrinol Metab; 2002 Jul; 13(5):220-5. PubMed ID: 12185669
[TBL] [Abstract][Full Text] [Related]
32. WNT4 mediates estrogen receptor signaling and endocrine resistance in invasive lobular carcinoma cell lines.
Sikora MJ; Jacobsen BM; Levine K; Chen J; Davidson NE; Lee AV; Alexander CM; Oesterreich S
Breast Cancer Res; 2016 Sep; 18(1):92. PubMed ID: 27650553
[TBL] [Abstract][Full Text] [Related]
33. Constitutive activities of estrogen-related receptors: Transcriptional regulation of metabolism by the ERR pathways in health and disease.
Huss JM; Garbacz WG; Xie W
Biochim Biophys Acta; 2015 Sep; 1852(9):1912-27. PubMed ID: 26115970
[TBL] [Abstract][Full Text] [Related]
34. Inhibition of ERRα suppresses epithelial mesenchymal transition of triple negative breast cancer cells by directly targeting fibronectin.
Wu YM; Chen ZJ; Liu H; Wei WD; Lu LL; Yang XL; Liang WT; Liu T; Liu HL; Du J; Wang HS
Oncotarget; 2015 Sep; 6(28):25588-601. PubMed ID: 26160845
[TBL] [Abstract][Full Text] [Related]
35. The orphan receptor ERRalpha interferes with steroid signaling.
Teyssier C; Bianco S; Lanvin O; Vanacker JM
Nucleic Acids Res; 2008 Sep; 36(16):5350-61. PubMed ID: 18697814
[TBL] [Abstract][Full Text] [Related]
36. Expression of human estrogen receptor using an efficient adenoviral gene delivery system is able to restore hormone-dependent features to estrogen receptor-negative breast carcinoma cells.
Lazennec G; Katzenellenbogen BS
Mol Cell Endocrinol; 1999 Mar; 149(1-2):93-105. PubMed ID: 10375022
[TBL] [Abstract][Full Text] [Related]
37. Progesterone metabolites regulate induction, growth, and suppression of estrogen- and progesterone receptor-negative human breast cell tumors.
Wiebe JP; Zhang G; Welch I; Cadieux-Pitre HA
Breast Cancer Res; 2013 May; 15(3):R38. PubMed ID: 25927181
[TBL] [Abstract][Full Text] [Related]
38. Epidermal growth factor-induced signaling in breast cancer cells results in selective target gene activation by orphan nuclear receptor estrogen-related receptor alpha.
Barry JB; Giguère V
Cancer Res; 2005 Jul; 65(14):6120-9. PubMed ID: 16024613
[TBL] [Abstract][Full Text] [Related]
39. Structure-based discovery of pyrazolamides as novel ERRγ inverse agonists.
Yang SH; Khadka DB; Han J; Na SY; Shin M; Kim DK; Oh BC; Kim EY; Choi HS; Cho WJ
Eur J Med Chem; 2023 Mar; 250():115174. PubMed ID: 36805944
[TBL] [Abstract][Full Text] [Related]
40. Flavone and isoflavone phytoestrogens are agonists of estrogen-related receptors.
Suetsugi M; Su L; Karlsberg K; Yuan YC; Chen S
Mol Cancer Res; 2003 Nov; 1(13):981-91. PubMed ID: 14638870
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
